Dr Reddy’s Q2 FY24 Results: Consolidated PAT Rises to Rs. 1482.2 Cr

Dr Reddy's Q2 FY24 Results: Consolidated PAT Rises to Rs. 1482.2 Cr

Dr Reddy’s Q2 FY24 Results Today

Dr Reddy’s Q2 results show revenue up from 6931.9 crores to 7217.6 crores, a 4.12% increase in growth. EPS rose from ₹84.55 to ₹89.09, up by 5.37%.

Quarter-on-Quarter Basis Results (Q2 FY2024):

Dr Reddy’s shared its Q2 results on Friday. They earned 7217.6 crores in revenue this quarter, but that’s more than the 6931.9 crores they made last quarter. The company’s growth increased by 4.12 percent when comparing the two quarters.

In terms of profits, the company’s PAT (Profit After Tax) for this quarter was 1482.2 crores, up from 1405.00 crores in the previous quarter. Their quarter-to-quarter growth increased by 5.49 percent.

The company’s EPS (Earnings Per Share) this quarter is ₹89.09, which is an increase of 5.37% from the ₹84.55 EPS in the previous quarter.

Year-over-Year Basis Results (Q2 FY2024):

The company made a total revenue of 7217.6 crores this year (2023), which is 13.26 percent higher than last year’s total revenue of 6372.6 crores.

This year’s PAT (Profit After Tax) is 1482.2 crores, which is also 33.03% higher than last year’s PAT of 1114.2 crores.

The EPS (Earnings Per Share) for this year is ₹89.09, which is 32.71% more than the EPS of ₹67.13 earned last year.

Year-over-Year Basis Results (Half Year Ended FY2024):

In the first half of 2023, the company generated a total revenue of 14,149.5 crores, marking a 13.68% increase compared to the previous year’s 12,447.2 crores.

The PAT (Profit After Tax) for this half-year stands at 2887.2 crores, showing a 25.36% growth over the previous year’s 2303.2 crores.

The EPS (Earnings Per Share) for this half-year is ₹173.64, representing a 25.13% increase from the previous half-year’s EPS of ₹138.77.

Dr Reddy’s Share Dividend Announcement / Record Date:

The record date for the dividend has not arrived yet.

About Dr Reddy’s:

Dr. Reddy’s Laboratories is a Hyderabad-based multinational pharmaceutical corporation in India. It was established by Kallam Anji Reddy, who had prior experience at the mentor institute, Indian Drugs and Pharmaceuticals Limited. Dr. Reddy’s Laboratories is engaged in the production and global distribution of a diverse array of pharmaceutical products both in India and abroad.

Download the Full PDF of Q2 Results: Click Here

For more of the Latest News, Click Here

Leave a Reply

Your email address will not be published. Required fields are marked *